Please provide your email address to receive an email when new articles are posted on . Adjusted analysis demonstrated no association between nucleos(t)ide analogue retreatment and HBsAg seroclearance ...
MedPage Today on MSN
Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns
But without a birth dose, about 90% of newborns who are infected perinatally will develop chronic HBV infection -- and ...
A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...
Please provide your email address to receive an email when new articles are posted on . HBV-infected children treated with combination PEG-INF a-2b/nucleos(t)ide analogues achieved higher HBsAg loss ...
Mean 60 mg HBsAg reduction of 0.99 log10 IU/mL at week 12, with normal ALT and AST values throughout the follow-up period 90 mg single-dose and 60 mg multi-dose cohorts initiated with data expected in ...
Hepatitis B virus (HBV), a partially double-stranded hepatotropic DNA virus, is the aetiological agent (Box 1; Fig. 1) of acute and chronic hepatitis B in humans. In countries where HBV prevalence is ...
Hepatitis B virus is often silently undiagnosed, with only 10.5% of all people estimated to be living with Hepatitis B aware of their condition. Abbott has launched the HBsAg Next Qualitative Assay ...
Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback